For example, the deletion of the DACH1 gene occurs in up to 18% of human prostate cancer cases, and its loss in mouse prostate cancer models has been shown to enhance prostatic intraepithelial neoplasia and DNA damage [6]. The gene discussed is DACH1; the disease is prostate carcinoma.